Mary Ann Liebert: Uncovering New Therapeutic Targets for Airway Inflammation in Sickle Cell Disease
September 30, 2019
September 30, 2019
NEW ROCHELLE, New York, Sept. 30 -- Mary Ann Liebert Inc. issued the following news release:
A new study by De, Agrawal, Morrone et al, challenges the common notion that airway inflammation in Sickle Cell Disease (SCD) is secondary to asthma, even though the two disorders often coexist. In a recent pilot, cross sectional study, both systemic and airway inflammatory markers were compared in patients with sickle cell disease with and without asthma or obstructive airway symptoms. Thei . . .
A new study by De, Agrawal, Morrone et al, challenges the common notion that airway inflammation in Sickle Cell Disease (SCD) is secondary to asthma, even though the two disorders often coexist. In a recent pilot, cross sectional study, both systemic and airway inflammatory markers were compared in patients with sickle cell disease with and without asthma or obstructive airway symptoms. Thei . . .